Bevacizumab after bevacizumab in platinum-sensitive recurrent ovarian cancer: A subgroup analysis of GOG0213.

被引：2
|
作者：
Coleman, Robert L.
Brady, Mark F.
Herzog, Thomas J.
Armstrong, Deborah Kay
Sabbatini, Paul
Walker, Joan L.
Kim, Byoung
Fujiwara, Keiichi
Tewari, Krishnansu Sujata
O'Malley, David M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Roswell Pk Canc Inst, NRG Stat & Data Ctr, Buffalo, NY USA
[3] Univ Cincinnati, Inst Canc, Div Gynecol Oncol, Cincinnati, OH USA
[4] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Weill Cornell Med Coll, New York, NY USA
[7] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[8] Sungkyunkwan Univ, Sch Med, Dept Obstet & Gynecol, Samsung Med Ctr, Seoul, South Korea
[9] Saitama Med Univ, Int Med Ctr, Hidaka, Japan
[10] UC Irvine Med Ctr, Orange, CA USA
[11] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5523
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5523
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Bevacizumab or PARP-inhibitors maintenance therapy for platinum-sensitive (PS) recurrent ovarian cancer (rOC)? A network meta-analysis (NMA).
    Bartoletti, Michele
    Pelizzari, Giacomo
    Gerratana, Lorenzo
    Garattini, Silvio Ken
    Basile, Debora
    Lisanti, Camilla
    Bortot, Lucia
    Corvaja, Carla
    Garutti, Mattia
    Scalone, Simona
    Nicoloso, Milena
    Bolzonello, Silvia
    Torrisi, Elena
    Da Ros, Lucia
    Di Nardo, Paola
    Lombardi, Davide
    Giorda, Giorgio
    Baldassarre, Gustavo
    Sorio, Roberto
    Puglisi, Fabio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
    Aghajanian, Carol
    Goff, Barbara
    Nycum, Lawrence R.
    Wang, Yan V.
    Husain, Amreen
    Blank, Stephanie V.
    GYNECOLOGIC ONCOLOGY, 2015, 139 (01) : 10 - 16
  • [23] Should Bevacizumab Be Continued After Progression on Bevacizumab in Recurrent Ovarian Cancer?
    Backes, Floor J.
    Richardson, Debra L.
    McCann, Georgia A.
    Smith, Blair
    Salani, Ritu
    Eisenhauer, Eric L.
    Fowler, Jeffrey M.
    Copeland, Larry J.
    Cohn, David E.
    O'Malley, David M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (05) : 833 - 838
  • [24] Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
    Backes, F.
    Richardson, D.
    McCann, G.
    Salani, R.
    Eisenhauer, E.
    Fowler, J.
    Copeland, L.
    Cohn, D.
    O'Malley, D.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S94 - S94
  • [25] Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer
    Richardson, Debra L.
    Backes, Floor J.
    Seamon, Leigh G.
    Zanagnolo, Vanna
    O'Malley, David M.
    Cohn, David E.
    Fowler, Jeffrey M.
    Copeland, Larry J.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (03) : 461 - 466
  • [26] Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer
    Richardson, D. L.
    Backes, F. J.
    Seamon, L. G.
    O'Malley, D. M.
    Cohn, D. E.
    Fowler, J. M.
    Copeland, L. J.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S13 - S13
  • [27] Secondary cytoreductive surgery for recurrent platinum-sensitive ovarian cancer
    Schorge, John O.
    Wingo, Shana N.
    Bhore, Rafia
    Heffernan, Thomas P.
    Lea, Jayanthi S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 108 (02) : 123 - 127
  • [28] Management of platinum-sensitive recurrent ovarian cancer: A cost-effectiveness analysis
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    Kulasingam, Shalini
    Myers, Evan
    GYNECOLOGIC ONCOLOGY, 2007, 107 (02) : 211 - 218
  • [29] Maintenance with Trabectedin in the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer
    Guerra Alia, Eva Maria
    Sempere Ortega, Cayetano
    Cortes Salgado, Alfonso
    Sanchez Martinez, Concepcion
    Galindo Alvarez, Julio
    Perez Miez, Belen
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 447 - 455
  • [30] NICE guidance on bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer
    Pinilla-Dominguez, Pilar
    Richardson, Joanna
    Robertson, Janet
    Adam, Jane
    LANCET ONCOLOGY, 2013, 14 (08): : 691 - 692
12345